Revolutionizing Healthcare with Early Disease Detection
Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
Abortion pills could be difficult to get as a federal judge in Texas is expected to rule as early as today if the FDA's approval of the drug will be overturned.
The Ohio Department of Natural Resources estimated that more than 38,000 minnows died with 5,500 additional species of fish, amphibians, and crayfish also possibly impacted by the toxic spill.
Transgender youth in Tennessee would be banned from receiving gender-affirming care under legislation currently headed to Republican Gov. Bill Lee’s desk.
Plant-based, non-dairy milk producers scored a win when the Food and Drug Administration issued guidance stating products like almond, oat, and soy options can be called milk.
The U.S. Environmental Protection Agency ordered Norfolk Southern on Tuesday to pay for the cleanup of the East Palestine, Ohio train wreck and chemical release.
